Arvinas, Inc. (ARVN) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Track Arvinas, Inc. (ARVN) stock performance with short-term forecasts for 2025 and long-term ARVN price prediction till 2050. Review historical trends, get analyst Buy/Sell/Hold ratings, and stay updated with the latest Arvinas, Inc. headlines.
1 Month Prediction
$50.05 [503.00%]
3 Month Prediction
$42.29 [409.53%]
6 Month Prediction
$49.34 [494.42%]
1 Year Prediction
$67.07 [708.01%]
3 Year Prediction
$56.37 [579.10%]
5 Year Prediction
$50.42 [507.45%]
About Arvinas, Inc.
Arvinas, Inc. is a clinical-stage biopharmaceutical company that develops therapies that degrade disease-causing proteins using its PROTAC (PROteolysis Targeting Chimera) technology.
The company was founded in 2013 by Yale professor Craig Crews, and is headquartered in New Haven, Connecticut.
Arvinas, Inc. (ARVN) Historical Performance
IPO Date
Arvinas, Inc. (NASDAQ:ARVN) went public on 26 September, 2018.
Change
Since inception, ARVN has decreased by 50.80%. In the last 5 years, ARVN has fallen from $52.50 to $8.30, a massive -84.19% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $101.10 and a low of $8.30.
52 Week Range
$7.91
$46.51
The current price $8.30 is near the 52-week low, which means that the stock is underbought.
ARVN Stock Price History
Based on ARVN stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the ARVN stock has fallen from $20.91 - $84.93 to $8.3 - $17.7, which is down -45.06%. Currently, the stock follows downward trend.
Here, we have calculated stock range of ARVN, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $20.91 - $84.93 | $38.86 | 46.84 | 1 Year Change |
| 2021 | $66.1 - $101.1 | $79.36 | 199.89 | 2 Year Change |
| 2022 | $34.21 - $71.49 | $50.6 | 91.21 | 3 Year Change |
| 2023 | $16.12 - $41.16 | $26.28 | -0.69 | 4 Year Change |
| 2024 | $19.17 - $45.98 | $30.91 | 16.8 | 5 Year Change |
| 2025 | $8.3 - $17.7 | $14.54 | -45.06 | 6 Year Change |
ARVN Price Performance
6-Month Performance
ARVN stock dropped by 68.60% in the last six months.
1-Year Performance
The stock has trended downwards by 73.87% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 84.90%.
5-Year Performance
In the last 5 years, the stock has gone down by 84.19%.
According to Arvinas, Inc.'s historical data, below graph gives us the exact picture of how the ARVN stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 2 years and a decline in 3 years.
2020
106.69% ↑
2021
3.29% ↓
2022
58.35% ↓
2023
20.32% ↑
2024
53.43% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Arvinas, Inc. (ARVN) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $59.20 M (Q4)
Revenue for Q4 ending 31st December, 2024 decreased 42.19% compared to Q3 ending 30th September, 2024.
Annual Revenue: $263.40 M (1Y)
Revenue for trailing 12 months decreased 0.00% year over year from 31st December, 2024.
Market Capitalization
Arvinas, Inc. has a market capitalization of $570.81M, which places ARVN in the small-cap category.
Fundamental Analysis
EPS: $nan (Q4), $-2.77 (1Y)
EPS decreased nan% since last quarter, and decreased 58.16% since last year.
Net Income: $-45.10 M (Q4), $-198.90 M (1Y)
Net Income decreased 8.33% since last quarter, and decreased 45.85% since last year.
Free Cash Flow: $-84.40 M (Q4), $-261.10 M (1Y)
Free Cash Flow decreased 34.42% since last quarter, and decreased 25.55% since last year.
Net Profit Margin: -76.18% (Q4), -75.51% (1Y)
Net Profit Margin increased 58.56% since last quarter, and decreased 45.85% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for ARVN stock. These indicators help you understand Arvinas, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for ARVN stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $17.20 |
| SMA50 | $17.99 |
| SMA200 | $23.95 |
| RSI | 20.40 |
| Beta | 1.96 |
SMA20 > Current Price
This signals ARVN stock is in short-term bearish momentum.
SMA50 > Current Price
This signals ARVN stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals ARVN stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for ARVN stock is Bearish. Out of all indicators, 3 indicates bullish signals, 6 signals bearish trends and 0 gives neutral trends. The ARVN stock forecast was last updated on 12 March, 2025.
Arvinas, Inc. (ARVN) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $65.28 by the end of 2025, and can reach around $70.04 to $47.86 in 2026. And, the long-term forecast suggests that the stock may further jump to $48.01 - $52.89 in 2028, and $27.31 - $29.36 by 2031. So, the ARVN stock shows a strong upward trend in the next several years.
Short-term ARVN Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $50.05 | 503.01% |
| 2025-05 | $48.95 | 489.76% |
| 2025-06 | $42.29 | 409.52% |
| 2025-07 | $45.17 | 444.22% |
| 2025-08 | $46.87 | 464.7% |
| 2025-09 | $49.34 | 494.46% |
| 2025-10 | $38.09 | 358.92% |
| 2025-11 | $45.04 | 442.65% |
| 2025-12 | $65.28 | 686.51% |
In 2025, the ARVN stock price is expected to fluctuate between $38.09 and $65.28. According to the monthly forecast, the stock could rise to $65.28 by December 2024. If compared to the ARVN's current price, the stock could gain 686.51% by the end of this year.
Long-term ARVN Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $70.04 | $57.94 | $47.86 | 476.63% |
| 2027 | $28.29 | $50.74 | $60.52 | 629.16% |
| 2028 | $48.01 | $41.96 | $52.89 | 537.23% |
| 2029 | $52.56 | $34.95 | $48.30 | 481.93% |
| 2030 | $29.34 | $58.76 | $48.68 | 486.51% |
| 2031 | $27.31 | $79.30 | $29.36 | 253.73% |
| 2032 | $42.91 | $44.49 | $27.75 | 234.34% |
| 2033 | $32.77 | $23.03 | $16.66 | 100.72% |
| 2034 | $45.26 | $23.52 | $29.91 | 260.36% |
| 2035 | $29.84 | $32.84 | $18.91 | 127.83% |
| 2036 | $28.87 | $28.16 | $19.40 | 133.73% |
| 2037 | $14.56 | $23.15 | $8.43 | 1.57% |
| 2038 | $22.80 | $26.36 | $10.72 | 29.16% |
| 2039 | $10.32 | $33.43 | $9.39 | 13.13% |
| 2040 | $16.89 | $23.11 | $4.23 | -49.04% |
| 2041 | $8.02 | $15.90 | $1.36 | -83.61% |
| 2042 | $2.81 | $12.96 | $1.44 | -82.65% |
| 2043 | $0.55 | $14.70 | $1.06 | -87.23% |
| 2044 | $1.05 | $5.02 | $1.08 | -86.99% |
| 2045 | $0.80 | $4.93 | $0.78 | -90.6% |
| 2046 | $0.68 | $2.92 | $1.18 | -85.78% |
| 2047 | $0.93 | $1.05 | $1.24 | -85.06% |
| 2048 | $1.26 | $0.86 | $0.63 | -92.41% |
| 2049 | $1.31 | $1.03 | $1.02 | -87.71% |
| 2050 | $0.83 | $1.13 | $0.90 | -89.16% |
| 2051 | $1.05 | $1.03 | $1.07 | -87.11% |
Arvinas, Inc. (ARVN) Stock Price Prediction & Forecast 2025
At the start of 2025, the ARVN stock was at $17.61. Today, it is trading at $8.30, which is -52.87% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $65.28 by December 2025 with a 686.51% change.
Arvinas, Inc. (ARVN) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the ARVN stock. During this period, the ARVN's price is forecasted to shift from $70.04 to $48.68, which is -30.50% loss.
In 2026, the stock would possibly open at $70.04, descends to $57.94 by mid-year, and wraps up at $47.86, reflecting a 476.64% increase from today's price. Further moving to 2030, the stock can kick off the year at $29.34, drop to $58.76 by mid-year, and finish at $48.68, which is 486.53% change from current price.
Arvinas, Inc. (ARVN) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $27.31 to $4.23, which is down 253.79%
In 2031, we can expect ARVN to fluctuate between $27.31 and $29.36, a shift indicating a 253.79% gain by year-end compared to current price. And Until 2040, ARVN can likely vary from $4.23 to $16.89. By the end of 2040, the stock could record a -49.09% fall from today's stock price.
Arvinas, Inc. (ARVN) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the ARVN stock can see an a downturn from $8.02 to $0.90 in this period. In 2041, the stock can experience a high of $15.90 by mid-year, closing the year at $1.36. This results in a 91.54% increase from today.
Moving towards the end of 2050, ARVN is projected to open the year at $0.83. The stock may peak to $1.13 during mid-year and finish the year at $0.90. Compared to the stock's current price, this translates to an overall loss of -89.19% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
ARVN Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | - | $0.14 | -4.90% ▼ | $3861.03 ▲ |
| TNYA | Tenaya Therapeutics, Inc. | - | $0.46 | -54.95% ▼ | $790.53 ▲ |
| MRSN | Mersana Therapeutics, Inc. | - | $0.54 | 4.07% ▲ | $519.39 ▲ |
| XERS | Xeris Biopharma Holdings, Inc. | - | $4.13 | 7.83% ▲ | $41.7 ▲ |
| PSTV | Plus Therapeutics, Inc. | - | $1.44 | 97.26% ▲ | $70.11 ▲ |
Last updated Mar 12 at 6:52 PM
ARVN : Buy, Sell Or Hold?
Analyst Ratings
Based on 20 analysts, 5 rated as a strong buy, 12 recommended a buy, 3 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 20 analysts, 5 analysts gave a strong buy rating, 14 a buy rating, 1 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for ARVN stock is Buy.
Expert Analysis
According to ARVN short-term and long-term forecast, Arvinas, Inc. shares are projected to go down by 89.16%, and reach a value of $0.90 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, ARVN has recorded 13/30 green days, which reflects a 61.904761904761905% positivity rate with a price volatility of 0.10%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that ARVN stock is undervalued. So, Based on ARVN prediction and analysis, it may be the best time to hold ARVN stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "ARVN” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.